Company news

MacroGenics, Inc. news in 2026

MacroGenics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

MacroGenics Announces Appointments of Emil Kuriakose, M.D., and Michael Vasconcelles, M.D., to Board of Directors

November 3, 2026

MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer

October 26, 2026

MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN

October 23, 2026

MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors

October 15, 2026

MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

September 9, 2026

MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position

August 13, 2026

MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program

August 11, 2026

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

July 23, 2026

MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals

July 1, 2026

MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval

June 22, 2026

MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum

May 14, 2026

MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation

May 13, 2026

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals

May 11, 2026

MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement

May 4, 2026

FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study

April 7, 2026

MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures

March 9, 2026

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

February 22, 2026

Decks in 2026